Supply Chain Council of European Union |

Gilead and Distributor Cleared to Directly Sell Coronavirus Drug

Gilead Sciences  (GILD) – Get Report and its distributor have been cleared to sell its remdesivir  coronavirus drug directly to hospitals, the U.S. Department of Health and Human Services said Thursday.

Shares of the Foster City, Calif., biopharma at last check were little changed at $63.05.

The drug, branded as Veklury, was being distributed across the U.S. by HHS, but Secretary Alex Azar said in a statement that federal government oversight of the allocation of remdesivir is not required “because the drug is no longer a scarce resource.”

Related posts

K-12 Course Material Sales Drop by $182M YTD — THE Journal


Rotary Club of Nashoba Valley part of mask distribution – The Item –


Cosmetic Dentistry Market Wholesalers, Developments with Suppliers By 2028


Leave a Comment